3Hofman M,Morrow GR,Roscoe JA,et al.Cancer patients’expectations of experiencing treatment-related side effects:A University of Rochester Cancer Center–Community Clinical Oncology Program study of 938 patients from community practices.Cancer,2004,101:851-857.
4Forlenza MJ,Hall P,Lichtenstein P,et al.Epide-miology of cancer-related,fatigue in the Swedish Twin Registry.Cancer,2005,104:2022-2031.
5Bower JE.Cancer-related fatigue:links with in-flammation in cancer patients and survivors.Brain Behav Immun,2007,21:863-871.
6Schubert C,Hong S,Natarajan L,et al.The asso-ciation between fatigue and inflammatory marker levels in cancer patients:a quantitative review.Brain Behav Immun,2007,21:413-427.
7Miller AH,Ancoli-Israel S,Bower JE,et al.Neu-roendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.J Clin Oncol,2008,26:971-982.
8Berger AM,Wielgus K,Hertzog M,et al.Patterns of circadian activity rhythms and their relationships with fatigue and anxiety/depression in women treated with breast cancer adjuvant chemotherapy.Support Care Cancer,2009,18:105-114.
9Rich TA.Symptom clusters in cancer patients and their relation to EGFR ligand modulation of the circadian axis.J Support Oncol,2007,5:167-174.
10Cleeland CS,Wang XS.Measuring and under-standing fatigue.Oncology,1999,13:91-97.
二级参考文献7
1Mendoza TR,Wang XS.The Rapid Assessment of Fatigue severity in Cancer Patients[J].Cancer,1999,85 (5):1186-1196.
2De Vries J,Michielsen HJ.Assessment of fatigue among working people:a comparison of six questionnaires[J].Occup Environ Med,2003,60(Suppl 1):110-115.
3Santiago-Palma J,Payne R.Palliative Care and Rehabilitation[J].Cancer,2001,92(Suppl 4):1049-1052.
4Jnan Santiago,Richard Payne.Palliative Care and Rehabilitation[J].Carcer Supplenent,2001,92:1049-1052.
5Gabrilove JL,Cleeland CS,Livingston RB,et al.Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients:Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing[J].J Clin Oncol,2001,19(11):2875-2882.
6Cleeland CS,Demetri GD,Glaspy J,et al.Identifying hemoglobin level for optimal quality of life:results of an incremental analysis (abstract)[J].Proc Am Soc Clin Oncol,1999,18:574.
9Hofman M,Morrow GR,Roscoe JA,et al.Cancer patients' expectations of experiencing treatment related side effects: A University of Rochester Cancer Center-Community Clinical Oncology Program study of 93 8 patients from community practices [ J ].Cancer, 2004, 101 ( 4 ) : 851-857.
